glp-1 obesity drug news today september 15 2025 A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio GLP-1 Market Trends and Global

Nian, H

DPP4 in Diabetic Nephropathy Research suggests that DPP4 may play a role in the receptor axis for advanced glycation end products (RAGE), which is crucial for the development of diabetic nephropathy

8 Participants not using CPAP were enrolled in trial 1 (234 participants), and those using CPAP were enrolled in trial 2 (235 participants)

Constipation occurs commonly with the use of Mounjaro, in about 6% to 7% of people

For those navigating a breast cancer diagnosis, there is hope but also cautionespecially until larger studies can confirm which patients may benefit most and when these medications are safest to use

It's what's called a "stereoisomer" of fructose, the sugar found in many fruits and vegetables